62088-10-2

Basic information

• Product Name: 4-(4-CHLORO-PHENYL)-3-OXO-BUTYRIC ACID ETHYL ESTER
• Synonyms: 4-(4-CHLORO-PHENYL)-3-OXO-BUTYRIC ACID ETHYL ESTER;4-Chloro-b-oxo-benzenebutanoic acid ethyl ester;Benzenebutanoic acid, 4-chloro-β-oxo-, ethyl ester
• CAS NO: 62088-10-2
• Molecular Formula: C₁₂H₁₃ClO₃
• Molecular Weight: 240.68
• Mol File: 62088-10-2.mol
• Article Data: 17

Chemical Properties

• Boiling Point: 320.591 °C at 760 mmHg
• Flash Point: 125.989 °C
• Appearance: /
• Density: 1.198 g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.52
• PKA: 10.31±0.46(Predicted)
• CAS DataBase Reference: 4-(4-CHLORO-PHENYL)-3-OXO-BUTYRIC ACID ETHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(4-CHLORO-PHENYL)-3-OXO-BUTYRIC ACID ETHYL ESTER(62088-10-2)
• EPA Substance Registry System: 4-(4-CHLORO-PHENYL)-3-OXO-BUTYRIC ACID ETHYL ESTER(62088-10-2)

Safety Data

• Hazardous Substances Data: 62088-10-2(Hazardous Substances Data)

Usage

Uses

4-(4-Chlorophenyl)-3-oxo-butyric Acid Ethyl Ester is a starting material in Leishmania N-Myristoyltransferase Inhibitors.

InChI:InChI=1/C12H13ClO3/c1-2-16-12(15)8-11(14)7-9-3-5-10(13)6-4-9/h3-6H,2,7-8H2,1H3

Upstream product

• 6148-64-7 ethyl potassium malonate 
• 1878-66-6 4-chlorophenylacetic Acid 
• 37517-78-5 magnesium bis(3-ethoxy-3-oxopropanoate) 
• 623-73-4 diazoacetic acid ethyl ester 
• 2788-86-5 4-Chlorostyrene oxide 
• 25026-34-0 4-chlorophenacetyl chloride 
• 14062-24-9 4-chloro-benzeneacetic acid, ethyl ester 
• 42201-84-3 1-ethoxy-1-(tert-butyldimethylsilyloxy)ethene 
• 2033-24-1 cycl-isopropylidene malonate 
• 64-17-5 ethanol 
• 1035695-08-9 5-[2-(4-chlorophenyl)-1-hydroxyethylidene]-2,2-dimethyl-1,3-dioxane-4,6-dione 
• 32864-38-3 tert-Butyl ethyl malonate 

Downstream Products

• 851728-87-5 ethyl 4-(4-chlorophenyl)-2-[(2-chlorophenyl)-hydrazono]-3-oxobutyrate 
• 1159576-77-8 ethyl (2Z)-3-amino-4-(4-chlorophenyl)but-2-enoate 
• 1521145-60-7 ethyl 4-(4-chlorophenyl)-2-fluoro-3-oxobutanoate 
• 6732-20-3 4-(4-chlorophenyl)-3-hydroxybutanoic acid 
• 7000-49-9 ethyl 4-(4-chlorophenyl)-3-hydroxybutanoate 
• 1359818-05-5 4-(4-chlorobenzyl)-2-dimethyl-amino-5-bromo-6H-1,3-oxazine-6-one 
• 1359818-04-4 5-bromo-4-(4-chlorobenzyl)-2-phenoxy-thiazole 
• 1359818-02-2 4-(4-chlorobenzyl)-2-phenoxy-thiazole 

Relevant articles and documents

Non-metal Lewis acid-catalyzed cross-Claisen condensation for β-keto esters

In this work, we disclose a new catalytic and highly chemoselective cross-Claisen condensation of esters. In the presence of TBSNTf2 as a non-metal Lewis acid, various esters can undergo cross-Claisen condensation to form β-keto esters which are important building blocks. Compared with the traditional Claisen condensation, this process, employing silyl ketene acetals (SKAs) as carbonic nucleophiles to achieve cross-Claisen condensation, requires mild conditions and has good tolerance of functional groups. This journal is

MACROCYCLIC FUSED PYRRAZOLES AS MCL-1 INHIBITORS

Provided are compounds represented by Formula IA: (IA), and the pharmaceutically acceptable salts and solvates thereof, wherein R, R 1a, R 1b, L 1, L 2, L 3, X, A, B and C are as defined as set forth

Heterocyclic derivative and pharmaceutical composition comprising the same

The present invention provides novel compounds having a P2X3 and/or P2X2/3 receptor antagonistic effect. A pharmaceutical composition having a P2X3 and/or P2X2/3 receptor antagonistic effect comprising a compoun